首页> 外文会议>The 16th International Conference on olid-State Sensors, Actuators and Microsystems >Delivery of an anti-cancer drug from a magnetically controlled MEMS device show cytotoxicity in PC3 and HUVEC cells
【24h】

Delivery of an anti-cancer drug from a magnetically controlled MEMS device show cytotoxicity in PC3 and HUVEC cells

机译:从电磁控制的MEMS装置中投放抗癌药后,对PC3和HUVEC细胞具有细胞毒性

获取原文

摘要

We have developed a magnetically controlled MEMS drug delivery device for on-demand release of defined quantities of an anti-cancer drug, docetaxel (DTX). A drug-loaded micro reservoir (Ø6mm×550µm) is sealed by a 40µm-thick elastic magnetic PDMS (polydimethylsiloxane) membrane with a laser-drilled aperture (∼100×100µm2). Discharge of the drug solution and the release rates are controlled by an external magnetic field. Controlled and reproducible release rates of DTX have been achieved for 35 days. We report on the cytotoxicity of the released drug from the device (monitored as cell viability) and show that DTX maintains cytotoxic effects for two months.
机译:我们已经开发出一种磁控MEMS药物输送装置,用于按需释放一定量的抗癌药物多西他赛(DTX)。装有药物的微型储液罐(Ø6mm×550μm)由厚度为40μm的带有激光钻孔(〜100×100μm 2 )的弹性磁性PDMS(聚二甲基硅氧烷)膜密封。药物溶液的排放和释放速率由外部磁场控制。 DTX的控制释放速率可重复35天。我们报告了从设备释放的药物的细胞毒性(监测细胞生存能力),并显示DTX可以维持两个月的细胞毒性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号